METHOD FOR COMPLEX TREATMENT OF INVASIVE CANCER OF CERVIX UTERI STAGES IIB-IIIB
The method for the complex treatment of the invasive cancer of cervix uteri stages IIb-IIIb comprises the combined radiotherapy in the setting of the oral use of hydroxyurea as radiomodifier. Throughout the course of the radiotherapy, hydroxyurea is taken at a dose of 40 mg/mL every third day. Lafer...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SHEVCHENKO HALYNA MYKOLAIVNA KHRULENKO TETIANA VALERIIVNA BARANOVSKA LIDIIA MYKHAILIVNA KURYLO HALYNA OMELIANIVNA IVANKOVA VALENTYNA STEPANIVNA |
| description | The method for the complex treatment of the invasive cancer of cervix uteri stages IIb-IIIb comprises the combined radiotherapy in the setting of the oral use of hydroxyurea as radiomodifier. Throughout the course of the radiotherapy, hydroxyurea is taken at a dose of 40 mg/mL every third day. Laferon at a dose of 1.106 IU or its analogue Intron A at a dose of 1.5.106 IU is administered intramuscularly. Upon the completion of the course of the combined radiotherapy, six 10-day courses of the supporting therapy with Laferon at a dose of 1.106 IU or Intron A at a dose of 1.5.106 IU are performed within six months. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_UA24394UU</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>UA24394UU</sourcerecordid><originalsourceid>FETCH-epo_espacenet_UA24394UU3</originalsourceid><addsrcrecordid>eNqFirEKwjAQQLM4iPoLcj_QxXZxPNOLPTCJJJfQrRSJk2ih_j9WcHd5Dx5vrbwl6XwLxgfQ3l4v1IMEQrHkBLwBdhkjZwKNTlP4pkWZe0hCgSEKnikC86niBVu1uo-Puex-3qi9IdFdVabXUOZpvJVneQ8JD019bFKq_w4fKgctxg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR COMPLEX TREATMENT OF INVASIVE CANCER OF CERVIX UTERI STAGES IIB-IIIB</title><source>esp@cenet</source><creator>SHEVCHENKO HALYNA MYKOLAIVNA ; KHRULENKO TETIANA VALERIIVNA ; BARANOVSKA LIDIIA MYKHAILIVNA ; KURYLO HALYNA OMELIANIVNA ; IVANKOVA VALENTYNA STEPANIVNA</creator><creatorcontrib>SHEVCHENKO HALYNA MYKOLAIVNA ; KHRULENKO TETIANA VALERIIVNA ; BARANOVSKA LIDIIA MYKHAILIVNA ; KURYLO HALYNA OMELIANIVNA ; IVANKOVA VALENTYNA STEPANIVNA</creatorcontrib><description>The method for the complex treatment of the invasive cancer of cervix uteri stages IIb-IIIb comprises the combined radiotherapy in the setting of the oral use of hydroxyurea as radiomodifier. Throughout the course of the radiotherapy, hydroxyurea is taken at a dose of 40 mg/mL every third day. Laferon at a dose of 1.106 IU or its analogue Intron A at a dose of 1.5.106 IU is administered intramuscularly. Upon the completion of the course of the combined radiotherapy, six 10-day courses of the supporting therapy with Laferon at a dose of 1.106 IU or Intron A at a dose of 1.5.106 IU are performed within six months.</description><language>eng</language><subject>ELECTROTHERAPY ; HUMAN NECESSITIES ; HYGIENE ; MAGNETOTHERAPY ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; RADIATION THERAPY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; ULTRASOUND THERAPY</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070625&DB=EPODOC&CC=UA&NR=24394U$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070625&DB=EPODOC&CC=UA&NR=24394U$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SHEVCHENKO HALYNA MYKOLAIVNA</creatorcontrib><creatorcontrib>KHRULENKO TETIANA VALERIIVNA</creatorcontrib><creatorcontrib>BARANOVSKA LIDIIA MYKHAILIVNA</creatorcontrib><creatorcontrib>KURYLO HALYNA OMELIANIVNA</creatorcontrib><creatorcontrib>IVANKOVA VALENTYNA STEPANIVNA</creatorcontrib><title>METHOD FOR COMPLEX TREATMENT OF INVASIVE CANCER OF CERVIX UTERI STAGES IIB-IIIB</title><description>The method for the complex treatment of the invasive cancer of cervix uteri stages IIb-IIIb comprises the combined radiotherapy in the setting of the oral use of hydroxyurea as radiomodifier. Throughout the course of the radiotherapy, hydroxyurea is taken at a dose of 40 mg/mL every third day. Laferon at a dose of 1.106 IU or its analogue Intron A at a dose of 1.5.106 IU is administered intramuscularly. Upon the completion of the course of the combined radiotherapy, six 10-day courses of the supporting therapy with Laferon at a dose of 1.106 IU or Intron A at a dose of 1.5.106 IU are performed within six months.</description><subject>ELECTROTHERAPY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MAGNETOTHERAPY</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>RADIATION THERAPY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>ULTRASOUND THERAPY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFirEKwjAQQLM4iPoLcj_QxXZxPNOLPTCJJJfQrRSJk2ih_j9WcHd5Dx5vrbwl6XwLxgfQ3l4v1IMEQrHkBLwBdhkjZwKNTlP4pkWZe0hCgSEKnikC86niBVu1uo-Puex-3qi9IdFdVabXUOZpvJVneQ8JD019bFKq_w4fKgctxg</recordid><startdate>20070625</startdate><enddate>20070625</enddate><creator>SHEVCHENKO HALYNA MYKOLAIVNA</creator><creator>KHRULENKO TETIANA VALERIIVNA</creator><creator>BARANOVSKA LIDIIA MYKHAILIVNA</creator><creator>KURYLO HALYNA OMELIANIVNA</creator><creator>IVANKOVA VALENTYNA STEPANIVNA</creator><scope>EVB</scope></search><sort><creationdate>20070625</creationdate><title>METHOD FOR COMPLEX TREATMENT OF INVASIVE CANCER OF CERVIX UTERI STAGES IIB-IIIB</title><author>SHEVCHENKO HALYNA MYKOLAIVNA ; KHRULENKO TETIANA VALERIIVNA ; BARANOVSKA LIDIIA MYKHAILIVNA ; KURYLO HALYNA OMELIANIVNA ; IVANKOVA VALENTYNA STEPANIVNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_UA24394UU3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>ELECTROTHERAPY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MAGNETOTHERAPY</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>RADIATION THERAPY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>ULTRASOUND THERAPY</topic><toplevel>online_resources</toplevel><creatorcontrib>SHEVCHENKO HALYNA MYKOLAIVNA</creatorcontrib><creatorcontrib>KHRULENKO TETIANA VALERIIVNA</creatorcontrib><creatorcontrib>BARANOVSKA LIDIIA MYKHAILIVNA</creatorcontrib><creatorcontrib>KURYLO HALYNA OMELIANIVNA</creatorcontrib><creatorcontrib>IVANKOVA VALENTYNA STEPANIVNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SHEVCHENKO HALYNA MYKOLAIVNA</au><au>KHRULENKO TETIANA VALERIIVNA</au><au>BARANOVSKA LIDIIA MYKHAILIVNA</au><au>KURYLO HALYNA OMELIANIVNA</au><au>IVANKOVA VALENTYNA STEPANIVNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR COMPLEX TREATMENT OF INVASIVE CANCER OF CERVIX UTERI STAGES IIB-IIIB</title><date>2007-06-25</date><risdate>2007</risdate><abstract>The method for the complex treatment of the invasive cancer of cervix uteri stages IIb-IIIb comprises the combined radiotherapy in the setting of the oral use of hydroxyurea as radiomodifier. Throughout the course of the radiotherapy, hydroxyurea is taken at a dose of 40 mg/mL every third day. Laferon at a dose of 1.106 IU or its analogue Intron A at a dose of 1.5.106 IU is administered intramuscularly. Upon the completion of the course of the combined radiotherapy, six 10-day courses of the supporting therapy with Laferon at a dose of 1.106 IU or Intron A at a dose of 1.5.106 IU are performed within six months.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_UA24394UU |
| source | esp@cenet |
| subjects | ELECTROTHERAPY HUMAN NECESSITIES HYGIENE MAGNETOTHERAPY MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES RADIATION THERAPY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ULTRASOUND THERAPY |
| title | METHOD FOR COMPLEX TREATMENT OF INVASIVE CANCER OF CERVIX UTERI STAGES IIB-IIIB |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A50%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SHEVCHENKO%20HALYNA%20MYKOLAIVNA&rft.date=2007-06-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUA24394UU%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |